Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction | MicrobiomeTrials← Back to trialsNCT07615023
Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-20Est. Completion: 2029-06-20
Enrollment target: 350 participants Locations- Medical University of Innsbruck, Innsbruck, Tyrol, Austria
Other microbiome trials you might be interested in
StrokeMedication Adherence
The overall objective of the Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II (S…
Kumasi, GhanaEst. completion Jul 1, 2028
Acute Coronary Syndrome (ACS)
CTQJ230A1US13 is a randomized, double-blind, placebo-controlled, multicenter phase IIIb study designed to evaluate the e…
Multiple LocationsEst. completion Dec 7, 2028
Completed
Ischemic Heart DiseaseST-segment Elevation Myocardial Infarction
Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains une…
Copenhagen, DenmarkCompleted Sep 1, 2025